Neurological Therapeutics
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
 
Multiple sclerosis and neuromyelitis optica ; key points for differential diagnosis
Ichiro Nakashima
Author information
JOURNAL FREE ACCESS

2022 Volume 39 Issue 3 Pages 192-194

Details
Abstract

Central nervous system demyelinating diseases include multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), MOG–IgG related disorders (MOGAD). The diagnosis of MS is based on the exclusion of other diseases and the findings of MRI and cerebrospinal fluid examination. The diagnosis of NMOSD and MOGAD requires the identification of anti–aquaporin 4 antibodies and anti–myelin oligodendrocyte glycoprotein antibodies, respectively, using a cell–based assay. In addition, it is important to know the characteristic clinical and imaging features of each disease.

Content from these authors
© 2022 Japanese Society of Neurological Therapeutics
Previous article Next article
feedback
Top